Zhu, Xuejing
Jing, Ran
Li, XiaoPing
Zhang, Wanfen
Tang, Yushang
Liu, Tongqiang
Article History
Received: 8 November 2022
Accepted: 19 February 2023
First Online: 9 March 2023
Declarations
:
: The studies involving human participants were reviewed and approved by the Clinical Research Ethics Committee of the Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University (approval number: 2021KY032-01). Written informed consents were obtained from the patients or their legally authorized representatives. All patient data were de-identified. All methods were carried out in accordance with relevant guidelines and regulations.
: Not-applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.